Stem cells show potential as post heart attack therapy
13th Sep 2005, 06:46 GMT
A preclinical trial conducted by Cytori Therapeutics has yielded results that support therapeutic opportunities for adult stem and regenerative cells derived from fat tissue in the treatment of cardiac injury following heart attack.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol